AccuMed International, Inc. has terminated the Patent and Technology License and Registration Rights Agreement with CellMetrix, Inc. All of the intellectual property, technology, and product rights licensed to CellMetrix have been returned to AccuMed.
Additionally, Ampersand Medical Corporation recently signed a Letter of Intent to merge with and into AccuMed International, Inc. The Company intends to pursue the commercialisation of the technology and field-of-use rights returned from CellMetrix.
AccuMed International, Inc., headquartered in Chicago, is an advanced diagnostics – and information-solutions company that designs, builds, and supplies cytology and histology products to improve the quality of cell-based specimen analysis.
The company’s product lines include the AcCell computer-aided microscopes and the AcCell-Savant quantitative imaging systems with powerful image-analysis software.
AccuMed has most recently focused on the customisation of these products for specific applications.